- About About
Medical Patient Resources Becoming a State-Authorized Patient Talking to your doctor The Medical Cannabis Patient’s Guide for U.S. Travel Patient's Guide to CBD Patient's Guide to Medical Cannabis Guide to Using Medical Cannabis Condition-based Booklets Growing Cannabis Cannabis Tincture, Salve, Butter and Oil Recipes Leaf411 Affordability Program Tracking Treatment & Gathering Data with Releaf App Medical Professional Resources CME for Medical Professionals Cannabis Safety Medical Cannabis Research
- Legal Legal
Advocacy ASA Chapters Start an ASA Chapter Take Action Campaigns No Patient Left Behind End Pain, Not Lives Vote Medical Marijuana Medical Cannabis Advocate's Training Center Resources for Tabling and Lobby Days Strategic Planning Civics 101 Strategic Messaging Citizen Lobbying Participating in Implementation Movement Building Organizing a Demonstration Organizing Turnout for Civic Meetings Public Speaking Media 101 Patient's History of Medical Cannabis
Policy Model Federal Legislation Download Ending The Federal Conflict Public Comments by ASA Industry Standards Guide to Regulating Industry Standards Recognizing Science using the Data Quality Act Fact Sheet on ASA's Data Quality Act Petition to HHS Data Quality Act Briefs ASA Data Quality Act petition to HHS Information on Lawyers and Named Patients in the Data Quality Act Lawsuit Reports 2020 State of the States Medical Cannabis Access for Pain Treatment Medical Cannabis in America
- Join Join
Becoming a Patient in Iowa
Only Iowa patients with intractable epilepsy are eligible to get a legal recommendation for CBD oil under SF 2360. They must obtain the recommendation from a neurologist has treated the patient for intractable epilepsy for at least six months. The physician need not be licensed in Iowa, so long as the physician's license is in good standing. Once obtaining a recommendation from a neurologist, the patient must register with the state Department of Public Health in order to have legal protection. The Department shall issue regulations more clearly defining the enrollment process later in 2014 or some time in 2015.
The program created under SF 2360 is extremely restrictive, only allowing access to CBD oil with less than 3% THC to patients with seizure disorders.
The only qualifying condition under SF 2360 is “intractable epilepsy,” which is defined in the law as an epileptic seizure disorder for which standard medical treatment does not prevent or significantly ameliorate recurring, uncontrolled seizures or for which standard medical treatment results in harmful side effects.
The application process will be developed by the Iowa Department of Public Health.
The law requires that a physician must be treating a patient for intractable epilepsy for at least six months prior to being eligible to recommend CBD oil to the patient. Only an allopathic or osteopathic physician board-certified in neurology may recommend CBD oil under Iowa law.
Caregivers are allowed under SF 2360. Caregivers must be at least 18 years of age and may not consume a patient's medicine. They must register when the patient applies to the Dept. of Public Health by submitting a similar application as the patient. Rules for the caregiver application process are currently being developed by the Iowa Dept. of Public Health.
There are no restrictions on how or where a patient may consumer their CBD oil; however, patients do not have access to cannabis in its dried flower form under SF 2360.
SF 2360 does not impose age restrictions.
The patient registry maintained by the Department of Public Health must be confidential. Authorized state employees may only access the confidential registry to confirm that a patient or caergiver in possession of CBD oil is registered in the program. Confidentiality must comply with federal HIPPA requirements.
The law is silent on housing protections for patients.
The law is silent on employment protections for patients.
The law is silent on insurance coverage.
Out of State patients
Iowa's CBD law does not have reciprocity for out of state patients
For More Information